ConductScience.org, home

Paper36980805

Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells.

Murwanti R and 5 others. Cancers (Basel), 2023. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells. Papers, record 36980805. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36980805

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Prevention of Inflammation-Driven Colon Carcinogenesis in Human MUC1 Transgenic Mice by Vaccination with MUC1 DNA and Dendritic Cells.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.51
iCite
Revised in PubMed
2023-03-31
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Murwanti RRetnohttps://orcid.org/0000-0002-4320-8210
2Denda-Nagai KKaorihttps://orcid.org/0000-0001-8325-3289
3Sugiura DDaisukehttps://orcid.org/0000-0002-3865-3889
4Mogushi KKaoru
5Gendler SJSandra J
6Irimura TTatsurohttps://orcid.org/0000-0002-4709-3131

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JP23689009Japan Society for the Promotion of SciencePubMed
JP21790144Japan Society for the Promotion of SciencePubMed
JP20K07163Japan Society for the Promotion of SciencePubMed
JP19790118Japan Society for the Promotion of SciencePubMed
JP21390018Japan Society for the Promotion of SciencePubMed
JP25293011Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

References62

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17905449MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma.Gastroenterology1994https://conductscience.org/library/papers/7905449PubMed
219426130Tumor-associated MUC1 glycopeptide epitopes are not subject to self-tolerance and improve responses to MUC1 peptide epitopes in MUC1 transgenic mice.Biol Chem2009https://conductscience.org/library/papers/19426130PubMed
319025220Aberrant expression of MUC1 mucin in pediatric inflammatory bowel disease.Pediatr Dev Pathol2010https://conductscience.org/library/papers/19025220PubMed
414611673A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate.Cancer Sci2003https://conductscience.org/library/papers/14611673PubMed
59143702DNA vaccines.Annu Rev Immunol1997https://conductscience.org/library/papers/9143702PubMed
69443411Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model.Cancer Res1998https://conductscience.org/library/papers/9443411PubMed
716776849Pilot phase III immunotherapy study in early-stage breast cancer patients using oxidized mannan-MUC1 [ISRCTN71711835].Breast Cancer Res2006https://conductscience.org/library/papers/16776849PubMed
831467405Dendritic cells in cancer immunology and immunotherapy.Nat Rev Immunol2020https://conductscience.org/library/papers/31467405PubMed
910837079DNA vaccines: immunology, application, and optimization*.Annu Rev Immunol2000https://conductscience.org/library/papers/10837079PubMed
1024188672Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1.Immunotherapy2013https://conductscience.org/library/papers/24188672PubMed
119200432The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites.J Immunol1997https://conductscience.org/library/papers/9200432PubMed
121195058Squamous metaplasia in the healing of chronic colonic ulcers of the rat.J Pathol1975https://conductscience.org/library/papers/1195058PubMed
1329193802A Synthetic MUC1 Anticancer Vaccine Containing Mannose Ligands for Targeting Macrophages and Dendritic Cells.ChemMedChem2018https://conductscience.org/library/papers/29193802PubMed
1419109152Progression of pancreatic adenocarcinoma is significantly impeded with a combination of vaccine and COX-2 inhibition.J Immunol2009https://conductscience.org/library/papers/19109152PubMed
159521319Dendritic cells and the control of immunity.Nature1998https://conductscience.org/library/papers/9521319PubMed
1623028615Local effects of regulatory T cells in MUC1 transgenic mice potentiate growth of MUC1 expressing tumor cells in vivo.PLoS One2012https://conductscience.org/library/papers/23028615PubMed
1723248097MUC1 vaccine for individuals with advanced adenoma of the colon: a cancer immunoprevention feasibility study.Cancer Prev Res (Phila)2013https://conductscience.org/library/papers/23248097PubMed
1811206842Absence of correlation of MUC1 expression to malignant behavior of renal cell carcinoma in experimental systems.Clin Exp Metastasis2000https://conductscience.org/library/papers/11206842PubMed
198813954Significance of MUC1 and MUC2 mucin expression in colorectal cancer.J Clin Pathol1996https://conductscience.org/library/papers/8813954PubMed
2017292519Intradermal vaccination of MUC1 transgenic mice with MUC1/IL-18 plasmid DNA suppresses experimental pulmonary metastases.Vaccine2007https://conductscience.org/library/papers/17292519PubMed

See all 62 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn PapersSource
41681861Cancer Prevention Clinical Trials: Advances and Challenges.Cancers (Basel)2026https://conductscience.org/library/papers/41681861PubMed
40211993Advanced Technologies for Cancer Immunotherapy: Focus on Gastrointestinal Cancers.Anticancer Agents Med Chem2025https://conductscience.org/library/papers/40211993PubMed
40154956SITC strategic vision: prevention, premalignant immunity, host and environmental factors.J Immunother Cancer2025https://conductscience.org/library/papers/40154956PubMed
39739658Identification of O-glycosylation related genes and subtypes in ulcerative colitis based on machine learning.PLoS One2024https://conductscience.org/library/papers/39739658PubMed
37886952The Potential of Dendritic Cell Subsets in the Development of Personalized Immunotherapy for Cancer Treatment.Curr Issues Mol Biol2023https://conductscience.org/library/papers/37886952PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MUC14582PubTator's text mininghttps://conductscience.org/library/genes/4582

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36980805

GET https://conductscience.org/api/papers/v1/36980805/references?page=2